Trial
NCT02441244
Probiotic Visbiome for Inflammation and Translocation in HIV Ι
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
CIHR Canadian HIV Trials Network
Condition
HIV-1 Infection
Intervention
Visbiome
Why stopped
Recruitment potential impaired by shift in clinical care whereby practically all HIV patients receive standard treatment as soon as possible after HIV diagnosis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-01